Draganfly Inc. (CSE:DPRO)

Achilles Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	141	32	31	34	69	70
Market Cap Growth	132.03%	1.56%	-7.50%	-51.01%	-1.07%	61.44%
Enterprise Value	118	28	29	22	41	69
Last Close Price	6.60	5.85	16.00	25.00	52.00	101.25
PS Ratio	19.65	4.84	4.77	4.45	9.78	15.98
PB Ratio	6.12	6.87	76.69	3.06	1.98	18.12
P/TBV Ratio	6.13	6.94	89.00	3.11	2.43	49.80
EV/Sales Ratio	16.54	4.27	4.49	2.87	5.78	15.90
Debt / Equity Ratio	0.02	0.09	2.15	0.04	0.02	0.07
Asset Turnover	0.37	0.71	0.57	0.27	0.29	0.85
Inventory Turnover	2.44	2.90	3.14	2.18	1.91	4.06
Quick Ratio	4.54	1.35	0.56	3.10	3.76	0.93
Current Ratio	5.29	1.74	0.90	4.04	4.99	1.39
Return on Equity (ROE)	-128.75%	-551.84%	-412.48%	-120.32%	-83.58%	-265.44%
Return on Assets (ROA)	-48.88%	-95.20%	-121.28%	-54.92%	-48.96%	-108.81%
Return on Capital (ROIC)	-87.87%	-278.57%	-217.81%	-66.29%	-60.83%	-174.64%
Earnings Yield	-9.32%	-43.70%	-75.52%	-81.81%	-23.49%	-11.49%
FCF Yield	-10.69%	-37.80%	-61.61%	-48.60%	-32.20%	-7.40%
Buyback Yield / Dilution	-149.38%	-94.95%	-20.64%	-20.76%	-67.82%	-73.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.